InsiderClue
← All stocks

GENELUX Corp

GNLX Net selling
CIK 0001231457 #4219 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$368.04K
$108.77K on a plan · $0.00 straight out of an exercise
Sold at will
$259.28K
22 of 25 sales
Net
−$368.04K
−$259.28K against sales at will

By person

12 insiders · 25 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Zindrick Thomas
President and CEO
—
$141.91K (5)
−$141.91K
1,226,427
2.71%
$3.38M
+2,093%
Thomas John
Director
—
$108.77K (3) scheduled
−$108.77K
501,193
1.11%
$1.38M
−0.9%
Cappello Joseph
Chief Technical Officer
—
$39.25K (5)
−$39.25K
318,480
0.7039%
$876.81K
+1,420%
Yu Yong
Chief Scientific Officer
—
$37.80K (5)
−$37.80K
258,688
0.5717%
$712.19K
+1,408%
Smither John W
Director
—
$34.90K (1)
−$34.90K
91,403
0.2020%
$251.64K
+73.4%
Smalling Ralph
Head of Regulatory
—
$5.42K (6)
−$5.42K
67,611
0.1494%
$186.14K
+259.0%
Pulisic Matthew
Chief Financial Officer
—
—
—
278,906
0.6164%
$767.86K
—
Groen Eric
General Counsel
—
—
—
233,957
0.5171%
$644.11K
—
Mirabelli Mary
Director
—
—
—
102,693
0.2270%
$282.72K
+97.5%
Tyree James L
Director
—
—
—
96,483
0.2132%
$265.63K
+95.9%
Zak Lourie S.
Chief Financial Officer
—
—
—
82,452
0.1822%
$227.00K
+92.2%
Ryder Sean
General Counsel
—
—
—
47,621
0.1053%
$131.11K
+145.6%

Individual transactions

25
Insider
Date
Role
Action
Shares
Price
Amount
Yu Yong
31 Aug 2026
Chief Scientific Officer
Sell
9,683
$2.75
$26.66K
Zindrick Thomas
31 Aug 2026
President and CEO
Sell
34,463
$2.67
$91.90K
Cappello Joseph
31 Aug 2026
Chief Technical Officer
Sell
10,257
$2.74
$28.11K
Zindrick Thomas
4 Aug 2026
President and CEO
Sell
3,023
$2.95
$8.91K
Cappello Joseph
4 Aug 2026
Chief Technical Officer
Sell
653
$2.95
$1.92K
Yu Yong
4 Aug 2026
Chief Scientific Officer
Sell
653
$2.94
$1.92K
Smither John W
1 Jul 2026
Director
Sell
12,000
$2.91
$34.90K
Smalling Ralph
3 Jun 2026
Head of Regulatory
Sell
192
$2.93
$562.56
Thomas John
1 Jun 2026
Director
Sold on a plan
10,000
$2.98
$29.80K
Smalling Ralph
11 May 2026
Head of Regulatory
Sell
270
$2.98
$804.49
Zindrick Thomas
11 May 2026
President and CEO
Sell
2,798
$2.94
$8.23K
Cappello Joseph
11 May 2026
Chief Technical Officer
Sell
605
$2.97
$1.80K
Yu Yong
11 May 2026
Chief Scientific Officer
Sell
605
$2.97
$1.80K
Smalling Ralph
25 Mar 2026
Head of Regulatory
Sell
240
$2.51
$602.40
Zindrick Thomas
24 Mar 2026
President and CEO
Sell
3,582
$2.42
$8.67K
Yu Yong
24 Mar 2026
SVP, Clinical Development
Sell
906
$2.42
$2.19K
Cappello Joseph
24 Mar 2026
Chief Technical Officer
Sell
906
$2.42
$2.19K
Smalling Ralph
24 Mar 2026
Head of Regulatory
Sell
345
$2.42
$834.90
Thomas John
2 Mar 2026
Director
Sold on a plan
10,000
$2.90
$28.96K
Smalling Ralph
5 Dec 2025
Head of Regulatory
Sell
165
$4.69
$773.85
Thomas John
1 Dec 2025
Director
Sold on a plan
10,000
$5.00
$50.01K
Smalling Ralph
17 Nov 2025
Head of Regulatory
Sell
343
$5.37
$1.84K
Cappello Joseph
17 Nov 2025
Chief Technical Officer
Sell
973
$5.37
$5.22K
Zindrick Thomas
17 Nov 2025
President and CEO
Sell
4,509
$5.37
$24.21K
Yu Yong
17 Nov 2025
SVP, Clinical Development
Sell
973
$5.37
$5.22K

What was left out

Form 4 filings counted 33
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 0
Sales at will 22
Transactions with no price 0
Shares from compensation/vesting 1,651,259
History held since 30 Jan 2023